lawsuit for glp 1 drugs GLP-1 Attorneys | Ashenden & Associates On February 2, 2026, Pope

These findings suggest GLP-1 receptor agonists may help reduce substance use and substance-related harms across alcohol, opioid, and tobacco use disorders

[6] Typically, they are mild and include soreness, redness, or itchiness around the injection site

Proven Weight Loss: Clinical studies, including the SURMOUNT-1 trial, have shown that Mounjaro can help people with obesity (without diabetes) lose an average of 15% to over 20% of their body weight

Severe or Persistent Side Effects: While mild gastrointestinal symptoms are expected initially, certain symptoms require prompt medical attention

In that way, it balances the actions of the GLP-1 pathway, ensuring blood sugar levels dont drop or spike above a certain threshold

doi: 10.1038/nn.2519, 73 KadouhH.ChedidV.HalawiH.BurtonD